Alphabet Is A Massive Cash Flow Machine With An Under-Leveraged Balance Sheet: Analyst
WestPark Capital initiated coverage on Alphabet with a Buy rating and $210 price target. Despite missing Q4 estimates, ...
来自MSN17 天
DWTX: First Patient Dosed in Phase 2b Trial of Halneuron in CINP; Debt Conversion ...
Phase 2 CRP Trial This was a randomized ... is a great strategic move by the company as it strengthens the balance sheet and eliminates any additional interest that would have been owed.